Two of the six vouchers in the second round went to GLP-1 drugs: Novo Nordisks semaglutide, directed toward a higher-dose formulation of Wegovy, and Eli Lillys orforglipron, an oral non-peptide small molecule that had not yet received FDA approval
Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC (1997) Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study
Who Should Consider L-Carnitine
The dose escalation schedule spans 16 to 20 weeks: 0.25 mg for four weeks, 0.5 mg for four weeks, 1.0 mg for four weeks, 1.7 mg for four weeks, and finally 2.4 mg as the maintenance dose
Q.MoormanJ
Jernimo, B.M